Quantcast

Latest Insulin Stories

2014-04-09 08:28:42

Research Projects Will Use Real-World Evidence to Support People Living With Type 1 Diabetes BOSTON and INDIANAPOLIS, April 9, 2014 /PRNewswire/ -- T1D Exchange and Eli Lilly and Company (NYSE: LLY) announced today they have entered into a research collaboration that will enable both organizations to gain deeper, real-world insight about the experience of people with type 1 diabetes, to identify new ways to improve care and advance outcomes. As part of this multi-year...

2014-04-09 08:28:28

Dario's Diabetes Management Solution Now Incorporates Regionally Localized Food Database to Better Manage Sugar Levels CAESAREA, Israel, April 9, 2014 /PRNewswire/ -- LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced a partnership with the world's leading global nutrition data application, FatSecret. The FatSecret platform is being integrated with Dario's powerful diabetes management software application to deliver...

2014-04-08 15:47:41

Researchers at the University of Adelaide have discovered that a common treatment for people with type 2 diabetes could cause longer-than-normal periods of the low blood sugar reaction hypoglycemia, which may result in increased health risks to people with diabetes. The treatment is the use of the peptide GLP-1 (glucagon-like peptide 1) in combination with insulin, which is now used throughout the world as a standard therapy for patients with type 2 diabetes. A team of researchers at...

2014-04-07 23:22:26

GIA announces the release of a comprehensive global report on Insulin Pumps (External) markets. Global market for Insulin Pumps (External) is forecast to reach US$1.7 billion by 2020, buoyed by rising obesity, high prevalence of diabetes, and the subsequent need to improve diabetes management. San Jose, California (PRWEB) April 07, 2014 Follow us on LinkedIn – Insulin Pump therapy, also known as Continuous Subcutaneous Insulin Infusion (CSII) therapy, has gained prominence over the...

2014-04-03 12:30:42

LONDON, April 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Global and China Insulin Industry Report, 2013-2017 As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 382 million in 2013 at a compound annual growth rate of 7.6%. And insulin as the important diabetes medication has also seen increasing...

2014-04-02 16:30:25

DUBLIN, April 2, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/37ktl3/global_and ) has announced the addition of the "Global and Chinese Insulin Industry Report - Forecasts to 2017" [http://www.researchandmarkets.com/research/37ktl3/global_and ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) As the third largest human health disease following neoplastic disease, cardiovascular and...

2014-04-01 23:27:11

ResearchMoz.us include new market research report "Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers" to its huge collection of research reports. Browse Full Report: http://www.researchmoz.us/insulin-delivery-devices-market-to-2019-simplified-pump-solutions-and-low-cost-pens-represent-distinct-regional-growth-drivers-report.html. Albany, NY (PRWEB) April 01, 2014 The report reviews the competitive...

2014-04-01 15:36:23

New research reveals that both pregnant women with diabetes and with type 2 diabetics have high levels of a fat metabolite that impairs pancreatic cells from secreting insulin. The findings, which are published in the April 1 issue of the Cell Press journal Cell Metabolism, suggest that blocking the effects of this fat metabolite may help prevent and treat diabetes. In nearly one-fifth of pregnancies, diabetes can arise (called gestational diabetes), and when this happens, it puts the...

2014-04-01 08:28:59

-Promising first interim phase 3 data for ITCA 650 in type 2 diabetes, combined with robust execution against key milestones and the addition of key talent BOSTON, April 1, 2014 /PRNewswire/ -- Intarcia Therapeutics, Inc. today announced the completion of another landmark private round of equity financing for $200 million. Together with the $210 million round of equity and debt financing in November of 2012 the company is very strongly positioned for future milestones and launch...

2014-03-31 08:29:38

SAN DIEGO, March 31, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the primary endpoint of non-inferiority of A1C levels at six months was met for the CONSISTENT 1 trial. The trial is evaluating Hylenex(® )recombinant and a new formulation of Hylenex currently under U.S Food and Drug Administration (FDA) review, when used as pretreatment of the insulin infusion site in patients with type 1 diabetes receiving continuous subcutaneous insulin...


Latest Insulin Reference Libraries

Pancreas
2013-01-02 11:22:15

The pancreas is a digestive and an endocrine organ with both endocrine and exocrine functions. It is about six inches long located in the upper portion of the abdominal cavity. The head of the pancreas lies within the indentation of the duodenum and is connected to it by the pancreatic duct. The uncinate process extends from the head and the neck connects to the body of the pancreas, which lies directly behind the stomach. The tail of the pancreas extends to the left side of the body and is...

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (2 articles) »
Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related